![glp-1 효과 새로운 수용체 작용제(Novel GLP-1 receptor agonists) 및 다중 작용제(GLP-1-based multi agonists): GIPR, GCGR, AMLNR 등을 표적으로 하는 구조 기반으로, 체중 감소, 인슐린 감수성 증가, 염증 억제 등을 포함한 대사질환 치료 동향리포트]GLP-1 수용체 작용제: 당뇨병 치료에서](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1217319213519075)
glp-1 효과 새로운 수용체 작용제(Novel GLP-1 receptor agonists) 및 다중 작용제(GLP-1-based multi agonists): GIPR, GCGR, AMLNR 등을 표적으로 하는 구조 기반으로, 체중 감소, 인슐린 감수성 증가, 염증 억제 등을 포함한 대사질환 치료 동향리포트]GLP-1 수용체 작용제: 당뇨병 치료에서
USD21.57
USD58.57
Pay in 4 interest-free payments of $5.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
![glp-1 (Novel GLP-1 receptor agonists) (GLP-1-based multi agonists): GIPR, GCGR, AMLNR , , , ]GLP-1 :](https://www.ibric.org/_attach/bric/editor-image/2024/09/TxhMkREFQcfdKBUXpECMgZdSHE.png)
![glp-1 (Novel GLP-1 receptor agonists) (GLP-1-based multi agonists): GIPR, GCGR, AMLNR , , , ]GLP-1 :](https://metamedic.s3.ap-northeast-2.amazonaws.com/froala_Img/1764816244172.jpg)
![glp-1 (Novel GLP-1 receptor agonists) (GLP-1-based multi agonists): GIPR, GCGR, AMLNR , , , ]GLP-1 :](https://img.etoday.co.kr/pto_db/2024/05/20240526161157_2029340_524_833.jpg)
![glp-1 (Novel GLP-1 receptor agonists) (GLP-1-based multi agonists): GIPR, GCGR, AMLNR , , , ]GLP-1 :](https://www.news-medical.net/images/news/ImageForNews_793033_17289642407124282.jpg)
